Frontlight ResearchEarly access
Trial site
Black Hills Regional Eye Institute
- 6running trials
- 6closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration9 trials
- Diabetic eye disease3 trials
- Phase
- Phase 39 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting4 trials
- Recruiting2 trials
- Withdrawn1 trial
- Lead sponsor
- 4D Molecular Therapeutics3 trials
- Alcon Research1 trial
- Apellis Pharmaceuticals, Inc.1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Bayer1 trial
- and 5 more
Running trials
Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Recruiting
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diabetic eye disease1 recruiting
- Macular degeneration1 recruiting
Closed trials
Withdrawn
Completed
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026